2 Struggling Stocks That Aren't Likely to Recover Anytime Soon

2 Struggling Stocks That Aren't Likely to Recover Anytime Soon

Two such stocks that could struggle for a long time to come are Ocugen (NASDAQ: OCGN) and Peloton Interactive (NASDAQ: PTON). Up until now, it has had nothing to show for its agreement with Bharat Biotech to help commercialize the Indian-based company's COVID-19 vaccine, Covaxin. Its agreements were to share in the profits of the vaccine in the Canadian and U.S. markets -- but Covaxin isn't approved for use in either country.